Lux Health Tech Acquisition Corp.

Status: Liquidated
U=S+W/3 W=S@11.5
IPO Proceeds, $M $345.00M
IPO Date Oct 27, 2020
CEO Josh DeFonzo
Left Lead Credit Suisse
IPO Cash in Trust 100.0%
SPAC Tenor 24 months
IPO Sector Healthcare

Healthcare and technology

IPO Geography Global
Target Company N/A
Deal Announced N/A
Deal Size, $M TBD
Deal Sector TBD
Deal Geography TBD
SEC Filings www.sec.gov
Approval Vote TBD
Amendment Vote TBD
Closing Date Oct 28, 2022
LUXA LUXAU LUXAW

Sign up for Free Trial

No credit card required

Sign in for more on Lux Health Tech Acquisition Corp.:

  • Structure and cap table
  • 6 directors & officers
  • 11 filings and events
  • 2 underwriters
Structure

Sign in to view structure, cap table, and calendar of events.

Team
Name Age Title
Peter Hébert 43 Chairman
Josh DeFonzo 39 CEO and Director
Segolene Scarborough 41 CFO and Treasurer
Bijan Salehizadeh 47 Director
Joseph Robert “Bob” Kerrey 76 Director
Fred Moll 68 Director

Sign in to view team biographies and more sponsor and affiliate data.

Advisors
Underwriters
Credit Suisse BR 24,000,000 units
Stifel Nicolaus 6,000,000
30,000,000 units
Up-Front UW fee 2.00 %
Deferred UW fee 3.50 %

Sign in to view more advisor data.

Filings

Sign in to view 11 filings.

Shareholders

Sign in to view shareholders 13F filing data.